Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

EBITDA Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual EBITDA in 2023 was -1.04 Million USD , down -283.45% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly EBITDA in 2023 Q4 was -585.49 Thousand USD , down -154.14% from previous quarter.
Vicapsys Life Sciences, Inc. reported an annual EBITDA of -984.79 Thousand USD in 2022, up 32.67% from previous year.
Vicapsys Life Sciences, Inc. reported an annual EBITDA of -305.54 Thousand USD in 2021, up 44.78% from previous year.
Vicapsys Life Sciences, Inc. reported a quarterly EBITDA of -211.27 Thousand USD for 2023 Q1, down -46.16% from previous quarter.
Vicapsys Life Sciences, Inc. reported a quarterly EBITDA of -230.38 Thousand USD for 2023 Q3, down -69.78% from previous quarter.

Annual EBITDA Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual EBITDA of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	EBITDA	EBITDA Growth
2023	-1.04 Million USD	-283.45%
2022	-984.79 Thousand USD	32.67%
2021	-305.54 Thousand USD	44.78%
2020	-734.42 Thousand USD	26.75%
2019	-1 Million USD	13.4%
2018	-1.15 Million USD	62.11%
2017	-3.05 Million USD	0.0%
2009	-1.22 Million USD	44.86%
2008	-2.24 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2023 Q4	-585.49 Thousand USD	-154.14%
2023 Q1	-211.27 Thousand USD	-46.16%
2023 Q3	-230.38 Thousand USD	-69.78%
2023 Q2	-135.69 Thousand USD	35.77%
2022 FY	- USD	32.67%
2022 Q2	-172.23 Thousand USD	-8.17%
2022 Q3	-137.25 Thousand USD	20.31%
2022 Q4	-144.55 Thousand USD	-5.32%
2022 Q1	-159.22 Thousand USD	-65.87%
2021 Q2	-64.24 Thousand USD	54.74%
2021 FY	- USD	44.78%
2021 Q4	-95.99 Thousand USD	7.12%
2021 Q3	-103.35 Thousand USD	-60.9%
2021 Q1	-141.94 Thousand USD	-95.22%
2020 Q3	-81.35 Thousand USD	63.64%
2020 Q2	-223.75 Thousand USD	37.25%
2020 FY	- USD	26.75%
2020 Q1	-356.59 Thousand USD	-45.98%
2020 Q4	-72.71 Thousand USD	10.63%
2019 Q2	-143.43 Thousand USD	7.92%
2019 FY	- USD	13.4%
2019 Q4	-244.27 Thousand USD	46.8%
2019 Q3	-459.12 Thousand USD	-220.08%
2019 Q1	-155.77 Thousand USD	-98.43%
2018 Q4	-78.5 Thousand USD	0.0%
2018 FY	- USD	62.11%
2017 FY	- USD	0.0%
2010 Q1	-595.05 Thousand USD	-39899.95%
2010 Q2	-1.33 Million USD	-124.08%
2009 FY	- USD	44.86%
2009 Q4	-1487.63 USD	0.0%
2009 Q2	-457.3 Thousand USD	-78.4%
2009 Q1	-256.33 Thousand USD	0.0%
2008 FY	- USD	0.0%

Peer EBITDA Comparison of Vicapsys Life Sciences, Inc.

Name	EBITDA	EBITDA Difference
America Great Health	-447.29 Thousand USD	-134.07%
Gene Biotherapeutics, Inc.	- USD	Infinity%
Evolutionary Genomics, Inc.	-913.47 Thousand USD	-14.615%
Innovation1 Biotech Inc.	-5.68 Million USD	81.579%
Point of Care Nano-Technology, Inc.	-73.41 Thousand USD	-1326.09%